{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Loglio A"],"funding":["Gilead Sciences"],"pagination":["e70336"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12410042"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["45(10)"],"pubmed_abstract":["<h4>Background and aims</h4>Hepatitis B (HBV) and Hepatitis Delta virus (HDV) infection have undergone significant changes in Italy over the past few decades, but reliable and updated prevalence of chronic hepatitis B (CHB) and Delta (CHD) data are lacking. The aim of the study was to describe the epidemiology of CHB and CHD in Italy in 2024, based on real-world data.<h4>Methods</h4>The number of patients with a healthcare expenditure exemption for CHB (016.070.32) and CHD (016.070.33) was obtained from 21 Regional Health Authorities. To understand how many CHB or CHD patients did not have these specific exemptions, a survey was conducted in 30 Gastroenterology, Hepatology and Infectious Diseases Units across the country.<h4>Results</h4>Health Authorities data reported 67 514 and 5216 subj"],"journal":["Liver international : official journal of the International Association for the Study of the Liver"],"pubmed_title":["Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database."],"pmcid":["PMC12410042"],"funding_grant_id":["Community Grant 2022","Global Community Grant ALL4LIVER 2023"],"pubmed_authors":["Russo FP","Ippolito AM","De Nicola S","Terreni N","Svegliati-Baroni G","Simone L","Schiada L","Coppola C","Ciancio A","Aghemo A","Pellicelli A","Gardini I","Toniutto P","Lampertico P","Pinchera B","Ponziani FR","Ciaccio A","Loglio A","Camma C","Claar E","Caraceni P","Bartoli M","Giannini EG","Gentile I","Sarmati L","Chessa L","Federico A","Conforti M","Morisco F","Sacerdoti D","D'Offizi G","Fagiuoli S","Degasperi E","D'Anto M","Romagnoli D","Nardone G","Silvia F","Colecchia A","Invernizzi P","Giaccherini C","Rosato V","Messina V","Cabibbo G","Niro GA","Colombatto P","Rocco A","Ieluzzi D","Muratori P","Vigano M","Brunetto MR"],"additional_accession":[]},"is_claimable":false,"name":"Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.","description":"<h4>Background and aims</h4>Hepatitis B (HBV) and Hepatitis Delta virus (HDV) infection have undergone significant changes in Italy over the past few decades, but reliable and updated prevalence of chronic hepatitis B (CHB) and Delta (CHD) data are lacking. The aim of the study was to describe the epidemiology of CHB and CHD in Italy in 2024, based on real-world data.<h4>Methods</h4>The number of patients with a healthcare expenditure exemption for CHB (016.070.32) and CHD (016.070.33) was obtained from 21 Regional Health Authorities. To understand how many CHB or CHD patients did not have these specific exemptions, a survey was conducted in 30 Gastroenterology, Hepatology and Infectious Diseases Units across the country.<h4>Results</h4>Health Authorities data reported 67 514 and 5216 subj","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-05-29T19:52:41.782Z","creation":"2026-04-08T05:54:54.36Z"},"accession":"S-EPMC12410042","cross_references":{"pubmed":["40905613"],"doi":["10.1111/liv.70336"]}}